Erimos Pharmaceuticals Announces Phase I Oral Study of Terameprocol (EM-1421)
Erimos Pharmaceuticals announced in collaboration with Adult Brain Tumor Consortium (ABTC) and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, initiation of a multi-center…
Read More...
Read More...
